Eleusis Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Reverse Merger
- (Cancelled)
- Latest Deal Amount
-
$446M
- Investors
-
8
Eleusis General Information
Description
Developer of psychedelic drug therapies intended to address unmet needs within and beyond psychiatry. The company's pipeline features a novel approach to transform psilocybin into a safe, effective, convenient, and affordable treatment alternative for depression, enabling healthcare providers and pharmaceutical companies to address a broad range of needs that are unmet by conventional therapies.
Contact Information
Website
www.eleusisltd.com
Formerly Known As
Eleusis Interim Holdings
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 50 Grosvenor Hill
- Mayfair
- London W1K 3QT
- England, United Kingdom
Eleusis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Reverse Merger | 20-Jan-2022 | $446M | Cancelled | Clinical Trials - General | ||
| 5. Later Stage VC | 08-Jul-2020 | 000.00 | Cancelled | Clinical Trials - General | ||
| 4. Later Stage VC (Series A) | 0000 | 000.00 | Completed | Clinical Trials - General | ||
| 3. Seed Round | 27-Jun-2016 | 00.000 | 00.000 | Completed | Clinical Trials - General | |
| 2. Grant | 01-Jul-2014 | $16.1K | $3.5M | Completed | Startup | |
| 1. Seed Round | $3.5M | $3.5M | Completed | Startup |
Eleusis Executive Team (7)
Eleusis Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Guyer MD | Self | Board Member | 000 0000 |
| David Socks | Self | Co-Chairman | 000 0000 |
| Esther Van Den Boom | Self | Board Member | 000 0000 |
| Joanna Natasegara | Self | Board Member | 000 0000 |
| John Tucker | Self | Board Member | 000 0000 |
Eleusis Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Eleusis Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| San Diego State University Research Foundation | Limited Partner | 000 0000 | 000000 0 | ||
| Ambria Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Neo Kuma Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Noetic Fund | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Palo Santo | Venture Capital | Minority | 000 0000 | 000000 0 |
Eleusis Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000 00000 | 15-Jan-2021 | 0000000000 | Clinics/Outpatient Services | 000000 00 |
Eleusis Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000 00000000 0 | Clinics/Outpatient Services | Corpus Christi, TX | 0000 |